The plan I'm looking at was published on 01/10/21 and it says:
"Vaccine-administration planning must reflect the four types of vaccines being manufactured:
mRNA or messenger ribonucleic acid
nonreplicating vector
protein adjuvant
live attenuated"
My understanding is there are relaxed storage requirements on the other vaccines, so I would be willing to bet my kidneys that you will largely see the non-mRNA vaccines being distributed in larger quantities to places like clinics and retail pharmacies (where most of the people here will be getting the vaccine) that only have standard refrigerated storage.
The plan I'm looking at was published on 01/10/21 and it says:
"Vaccine-administration planning must reflect the four types of vaccines being manufactured:
mRNA or messenger ribonucleic acid
nonreplicating vector
protein adjuvant
live attenuated"
My understanding is there are relaxed storage requirements on the other vaccines, so I would be willing to bet my kidneys that you will largely see the non-mRNA vaccines being distributed in larger quantities to places like clinics and retail pharmacies (where most of the people here will be getting the vaccine) that only have standard refrigerated storage.